DMAA
NASDAQ · N/A
Drugs Made In America Acquis
$10.63
+0.00 (+0.00%)
Open$10.64
Previous Close$10.63
Day High$10.66
Day Low$10.63
52W High$10.65
52W Low$10.17
Volume—
Avg Volume46.4K
Market Cap258.55M
P/E Ratio38.84
EPS$0.22
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 219.69M | 205.61M | 216.54M |
| Net Income | 25.03M | 23.39M | 21.58M |
| Profit Margin | 11.4% | 11.4% | 10.0% |
| EBITDA | 37.03M | 38.19M | 42.37M |
| Free Cash Flow | 19.51M | 14.22M | 14.32M |
| Rev Growth | -5.7% | -2.0% | +21.2% |
| Debt/Equity | 0.87 | 0.86 | 1.14 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.33 | +0.96% | — | 3.76B |
| PICS | Pics Nv | $11.06 | -1.60% | 6.4 | 1.43B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.20% | 74.9 | 642.73M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 594.36M |